Seres Therapeutics
MCRB
#8807
Rank
S$0.20 B
Marketcap
S$22.38
Share price
3.54%
Change (1 day)
-2.41%
Change (1 year)

Revenue for Seres Therapeutics (MCRB)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of S$0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seres Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 S$0.16 B1641.64%
2022 S$9.55 M-95.12%
2021 S$0.19 B345.88%
2020 S$43.94 M-5.54%
2019 S$46.51 M20.46%
2018 S$38.61 M-10.05%
2017 S$42.93 M36.3%
2016 S$31.5 M
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Xencor
XNCR
S$0.21 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
S$58.11 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA